Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

IGF-1 lr3

Long R3 IGF-1, LR3-IGF-1, Insulin-like Growth Factor-1 Long Arg3

Quick Stats
Studies 41
Trials 0
Score 3
1996 pubmed

The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis.

Donnelly. M J MJ; Holly. J M JM

Key Findings

  • IGF‑I and Des[1‑3] increase IGFBP‑3 production and cause dose‑dependent IGFBP‑4 proteolysis
  • LR3 does not induce IGFBP‑4 proteolysis because it does not bind IGFBP‑3
  • Excess IGFBP‑3 can block IGF‑I‑ and Des[1‑3]‑induced IGFBP‑4 breakdown

Practical Outcomes

  • For biohackers using IGF‑1 LR3, the data suggests LR3 may avoid triggering IGFBP‑4 proteolysis, potentially leading to a more consistent IGF signal compared to regular IGF‑I. However, the findings are from cell culture, so real‑world dosing or safety implications remain uncertain and should be tested cautiously.

Summary

The study shows that regular IGF‑I and the analog Des[1‑3] cause breakdown of IGFBP‑4, a protein that normally holds IGF in check, and this breakdown needs IGFBP‑3. The LR3 analog, however, does not trigger this breakdown because it doesn’t bind IGFBP‑3. This means LR3 may keep IGF‑1 activity more stable without prompting the body’s own protein‑cleaving response, at least in skin cells in a dish.

Abstract

The biological effects of insulin-like growth factors (IGFs) are mediated by cell surface receptors but their bioavailability is regulated by IGF binding proteins (IGFBPs) which bind IGF with higher affinity than the receptor. Proteolytic cleavage of the binding proteins reduces their affinity for IGF making the IGF more available to the cell receptor. In the current study we have examined the regulation of IGFBP-4 protease produced by cultured human dermal fibroblasts. IGF-I and the analogs of IGF-I (LR3 and Des[1-3]) induced a dose dependent increase in both proliferation and IGFBP-3 production. Low concentrations of IGF-I induced a marked loss of IGFBP-4 by Western ligand blotting (WLB). This effect was confirmed by the ability of media collected from cells exposed to increasing concentrations of IGF-I to fragment recombinant IGFBP-4, an effect blocked by EDTA. IGFBP-4 proteolysis was observed when cells were exposed to Des[1-3] (albeit at higher concentrations) but not with LR3. Both analogs bind to the IGF receptor but do not bind to IGFBP-4 and have reduced (Des[1-3]) or no (LR3) affinity for IGFBP-3. This demonstrated that neither receptor activation nor ligand binding directly to IGFBP-4 was necessary for IGF induced proteolysis. Protease activity correlated with affinity for IGFBP-3 suggesting a role for IGFBP-3 in the regulation of IGFBP-4 proteolysis. This was confirmed by the ability of excess recombinant IGFBP-3 to inhibit the IGF-I and Des[1-3] induced proteolysis of IGFBP-4. Addition of IGF-I to media from cells unexposed to IGF induced IGFBP-4 proteolysis but this was not seen with LR3 which does not bind to IGFBP-3. Fragmentation occured at higher concentrations of Des[1-3] consistent with its reduced affinity for IGFBP-3. This data suggests that IGFBP-4 proteolysis is regulated in a novel manner by IGFBP-3 which is dependent on the relative proportions of the different binding proteins and the levels of IGFs.

Study Information

Provider

pubmed

Year

1996

DOI

10.1677/joe.0.149r001